Evidence map›Paper›PMID 42095945›Full record

ArticleJournal of molecular modeling2026

Halogen bond-driven azo-hydrazone tautomerisation: a computational study.

Antti Siiskonen, Arri Priimagi

Abstract read
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antti SiiskonenFaculty of Engineering and Natural Sciences, Smart Photonic Materials, Tampere University, Korkeakoulunkatu 3, Tampere, 33720, Finland.ORCID http://orcid.org/0000-0003-3718-2031
Arri PriimagiFaculty of Engineering and Natural Sciences, Smart Photonic Materials, Tampere University, Korkeakoulunkatu 3, Tampere, 33720, Finland. arri.priimagi@tuni.fi.ORCID http://orcid.org/0000-0002-5945-9671

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAzo-hydrazone tautomerisation affects the photoswitching behaviour and physical properties of tautomerisable azobenzenes. Non-covalent interactions, such as halogen bonding, can shift the tautomeric equilibrium by stabilising one tautomer over the other. Here, we have used computational methods to study how halogen bonding affects the azo-hydrazone tautomerisation of 2-hydroxy- and 4-hydroxyazobenzenes and their azonaphthalene derivatives. We also studied the effect of alkoxy groups, commonly employed as attachment points when incorporating azobenzenes into functional polymeric systems, on tautomerisation and halogen bonding by systematically replacing ring hydrogens with methoxy groups. In addition, self-complementary halogen-bonded dimers based on 2'-iodo-2-hydroxyazonaphthalene bearing methoxy and nitro groups were studied. Our results show that halogen bonding generally shifts the tautomeric equilibrium towards the hydrazone form. When the azo tautomer is only slightly more stable (∆G = 0-2 kcal mol

methodsThe Gaussian 16 program was used for geometry optimisations, interaction energy calculations, and to generate the wavefunctions. All calculations were performed using the M06-2X/DGDZVP density functional theory method. The counterpoise correction method by Boys and Bernardi was used to correct for the basis set superposition error. The AIMAll program was used to perform the interacting quantum atoms analyses of the wavefunctions.

Indexed as

AzobenzeneDensity functional theoryHalogen bondingTautomerisation

Identifiers

PMID42095945
PMCPMC13152965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.